Navigation Links
Jennerex Presents Positive Clinical Data from Phase 2 Trial of JX-594 in Sorafenib-Refractory Liver Cancer Patients
Date:9/17/2012

currently in an international, randomized Phase 2b clinical trial (TRAVERSE) in patients with advanced primary liver cancer who have failed sorafenib therapy. In addition, JX-594 is being tested in the same patient population in combination with sorafenib. JX-594 is also in a Phase 1/2 clinical trials in patients with treatment-refractory colorectal cancer. Published studies designed to establish optimal dose levels and the safety profile of JX-594 have shown its ability to selectively target and cause destruction of a variety of common solid tumor types and trigger a potent immune response. JX-594 and other product candidates under development are designed to attack cancer tumors through three diverse mechanisms of action: the lysis of cancer cells through targeted viral replication, the ablation of the blood supply to tumors and the stimulation of the body's immune response against the cancer. Jennerex is headquartered in San Francisco and has related research and development operations in Ottawa, Canada and Pusan, South Korea. For more information about Jennerex, please visit www.jennerex.com. For studies evaluating JX-594 please visit www.clinicaltrials.gov.


'/>"/>
SOURCE Jennerex, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Jennerex Announces First Patient Treated in Phase 2 Clinical Trial of Intravenous Delivery JX-594 In Patients with Advanced Liver Cancer
2. Jennerex Appoints Dr. Laurent Fischer as President and Chief Executive Officer
3. Sorbent Therapeutics Presents CLP1001 Phase 2a Study Results at the 16th Annual Meeting of the Heart Failure Society of America
4. Mettler Toledo Presents In-depth Guidance to Comply with New USP Chapters 41 and 1251 on Balances Used for Quantitative Analysis in the Pharma QC Lab
5. Elevation Pharmaceuticals Presents Positive Phase 2b Results for EP-101 in COPD Patients at the European Respiratory Society Annual Congress
6. Informex Global Pharma Sourcing 2012 Presents Key Strategies & Insight For Business Success
7. Epigenomics Presents Significant Opportunities for Investment and Product Development, According to New Biotech Market Research
8. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
9. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
10. Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.s $1.04 Billion Civil Settlement with GlaxoSmithKline
11. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... ANGELES , Aug. 27, 2014   Los ... now offers AcceleDent® Aura to patients who want to ... orthodontic care available at the OrthoSpaceship, all patients have ... better-looking teeth. This system can be used by most ... their rate of progress by using the AcceleDent® Aura ...
(Date:8/27/2014)... -- Decision Resources Group finds that the intense physician ... health system and hospital sector in recent years ... Le Bonheur Healthcare and Baptist Memorial Health Care pulling ... In addition, a national contract recently signed between Tenet ... in the Memphis market, sets ...
(Date:8/27/2014)... August 27, 2014 According ... Products (Dental Radiology, CAD/CAM, Dental Chairs, Dental Lasers), Current Trends, ... MarketsandMarkets, the global Dental Equipment Market is expected to ... in 2014, growing at a CAGR of 5.7% ... market data tables and 61 figures spread through ...
Breaking Medicine Technology:Los Angeles Orthodontist, Dr. Isaac Hakim, is Now Offering AcceleDent Aura 2Memphis-area Health Systems Turn Attention to Clinical Integration 2Dental Equipment Market Worth $7,138.9 Million by 2019 2Dental Equipment Market Worth $7,138.9 Million by 2019 3
... Ten percent of cancer patients failed to fill their initial prescriptions ... today in the Journal of Oncology Practice ( JOP ... ). The study was based on an analysis conducted by Avalere ... 2007 to 2009. This study has also been accepted for presentation ...
... The Consumer Healthcare Products Association (CHPA), representing makers ... applauds the U.S. Food and Drug Administration (FDA) ... children the right amount of medicine. Today, the ... Committee recommended enhancing the labels of all OTC ...
Cached Medicine Technology:New Study Finds That 10% of Cancer Patients Abandoned Oral Anti-Cancer Drugs 2New Study Finds That 10% of Cancer Patients Abandoned Oral Anti-Cancer Drugs 3New Study Finds That 10% of Cancer Patients Abandoned Oral Anti-Cancer Drugs 4OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 2OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions 3
(Date:8/27/2014)... Holbrook, CP LP, has joined Fourroux Prosthetics, headquartered in ... experience in the prosthetics field. He graduated from ... Science degree with a major in biology and a ... in prosthetics at Northwestern University in Chicago, Illinois. , ... Fourroux,” says Keith Watson, owner of Fourroux. “His ...
(Date:8/27/2014)... For nearly two decades, audiences around the ... singers Deva Premal & Miten with their rapturous Nepali ... latest album in May, their 2014 MANTRAS FOR LIFE ... the globe, including Russia, Ukraine, Israel, Australia, the U.S., ... a new album and a new five-piece band, the ...
(Date:8/27/2014)... (HealthDay News) -- In a new study done from ... your blood pressure steadily increases if you ascend to ... widely used to treat high blood pressure was ineffective ... findings, reported online Aug. 27 in the European ... but those at sea level who have sleep apnea, ...
(Date:8/27/2014)... (HealthDay News) -- A new genetic discovery about Crohn,s ... bowel disorder, researchers report. The scientists pinpointed ... their genes work, and said these changes can be ... possibility of a simple diagnostic test for Crohn,s, the ... and suggest possible gene targets for new treatments, said ...
(Date:8/27/2014)... Princeton, NJ (PRWEB) August 27, 2014 ... revenue enhancement and protection services for hospitals, is pleased ... 2014 Inc. 5000 List of America’s Fastest-Growing Companies. The ... segment of the economy—America’s independent entrepreneurs. , "It's ... are honored to be included in this year's Inc. ...
Breaking Medicine News(10 mins):Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:Everest Study Finds High Altitude Affects Blood Pressure 2Health News:Scientists Spot Genetic Clues to Crohn's Disease 2Health News:BESLER Consulting Among America’s Fastest Growing Private Companies 2
... Blue Cross Blue Shield of Michigan announced today that Kevin ... current vice president for products and marketing, will succeed Jeanne ... when Carlson retires at the end of February 2010. , ... and CEO of BCBSM, parent company of Blue Care Network. ...
... - Proposed 30-Year Lease Agreement Will Help Stevens Hospital Expand, ... Wash., Dec. 17 The Board of Commissioners for Public ... for Swedish to lease and assume management of Stevens Hospital ... agreements. The public is invited to a hearing in mid-January ...
... from physician, study finds , THURSDAY, Dec. 17 (HealthDay News) ... parents to place infants on their backs to go to ... SIDS, researchers have found. , Since the U.S. government launched ... infants placed on their backs at sleep time has increased ...
... checkout counters of clothing stores, gas stations -- and adding ... News) -- If you,re hungry while shopping for a new ... sell sweet or salty snacks, a new report finds. , ... far beyond grocery stores to hit most segments of the ...
... ... Fisher Theatre on Dec. 17 for the Detroit-area,premiere of the award-winning musical “Jersey Boys,” Beaumont ... , ... When the cast takes the stage at the Fisher Theatre on Dec. 17 for the ...
... might be more likely to try alcohol, illegal drugs ... believe that smoking cigarettes is riskier than using illicit ... , That perception may increase the likelihood that they,ll ... said. , "We are on the right track with ...
Cached Medicine News:Health News:Stevens Hospital to Affiliate with Swedish 2Health News:Stevens Hospital to Affiliate with Swedish 3Health News:Stevens Hospital to Affiliate with Swedish 4Health News:Doctor's Orders Influence Baby's Sleep Position 2Health News:Wide Array of Stores Now Sell High-Calorie Snacks 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 2Health News:Jersey Boys' Premiere Benefits Cancer Patients While Launching Beaumont Hospitals Fundraising Campaign 3Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2
Inquire...
Inquire...
Protects the skin over extended wearing time from irritating discharge. Flextend skin barrier is the barrier of choice for urostomies and ileostomies with the added benefit of it being discreet in bo...
Inquire...
Medicine Products: